Hirokazu Nagai Selected Research

Hirokazu Nagai Research Topics

Disease

27	Neoplasms (Cancer) 01/2023 - 12/2002
15	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2024 - 05/2006
15	Lymphoma (Lymphomas) 11/2023 - 09/2003
12	Non-Hodgkin Lymphoma (Lymphosarcoma) 11/2023 - 01/2008
11	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2023 - 09/2010
10	Multiple Myeloma 01/2023 - 07/2010
9	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 05/2024 - 12/2016
9	B-Cell Lymphoma (Lymphoma, B Cell) 05/2024 - 12/2008
9	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 12/2023 - 10/2017
7	Hodgkin Disease (Hodgkin's Disease) 02/2015 - 01/2008
6	Disease Progression 05/2024 - 07/2012
6	Infections 08/2021 - 09/2011
6	Squamous Cell Carcinoma of Head and Neck 01/2021 - 07/2003
6	Mouth Neoplasms (Oral Cancer) 01/2014 - 08/2009
5	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2023 - 07/2012
5	Neutropenia 12/2021 - 10/2005
4	Fever (Fevers) 01/2023 - 08/2013
4	Hemorrhage 01/2023 - 09/2017
4	Hematologic Neoplasms (Hematological Malignancy) 12/2021 - 12/2006
3	Neoplasm Metastasis (Metastasis) 01/2023 - 02/2013
3	T-Cell Lymphoma (Lymphoma, T Cell) 01/2023 - 01/2013
3	Leukopenia 01/2017 - 10/2005
3	Acquired Immunodeficiency Syndrome (AIDS) 10/2016 - 06/2010
3	Febrile Neutropenia 08/2013 - 08/2012
2	Diarrhea 12/2022 - 12/2020
2	Wounds and Injuries (Trauma) 08/2021 - 09/2017
2	Hypersensitivity (Allergy) 08/2021 - 09/2017
2	Virus Diseases (Viral Diseases) 08/2021 - 09/2017
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 06/2021 - 12/2020
2	Leukemia 07/2020 - 01/2013
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 03/2020 - 04/2018
2	HIV Infections (HIV Infection) 09/2018 - 10/2016
2	Lymphatic Metastasis 02/2011 - 08/2009
1	Hypertension (High Blood Pressure) 01/2024
1	Pruritus (Itching) 01/2024
1	Erythema 01/2024
1	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 12/2023
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 08/2023
1	COVID-19 01/2023

Drug/Important Bio-Agent (IBA)

22	Rituximab (Mabthera)FDA Link 05/2024 - 12/2008
9	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2024 - 06/2018
9	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2024 - 06/2018
9	Dexamethasone (Maxidex)FDA LinkGeneric 10/2022 - 07/2010
8	Vincristine (Oncovin)FDA LinkGeneric 05/2024 - 06/2018
8	Bortezomib (Velcade)FDA Link 01/2023 - 03/2013
7	Prednisone (Sone)FDA LinkGeneric 05/2024 - 06/2018
6	Prednisolone (Predate)FDA LinkGeneric 01/2023 - 01/2020
5	Lenalidomide (CC 5013)FDA Link 12/2023 - 07/2010
5	Bendamustine Hydrochloride FDA Link 11/2023 - 09/2010
4	Brentuximab VedotinIBA 12/2023 - 03/2014
4	Anaplastic Lymphoma KinaseIBA 01/2023 - 07/2012
4	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 10/2002
4	Cisplatin (Platino)FDA LinkGeneric 11/2020 - 07/2003
4	Proteins (Proteins, Gene)FDA Link 07/2020 - 05/2006
4	Docetaxel (Taxotere)FDA Link 09/2012 - 10/2005
3	darinaparsinIBA 12/2023 - 02/2021
3	ibrutinibIBA 11/2023 - 12/2016
3	Melphalan (Alkeran)FDA LinkGeneric 01/2023 - 01/2021
3	Biomarkers (Surrogate Marker)IBA 12/2021 - 05/2005
3	Gemcitabine FDA Link 11/2020 - 10/2019
3	forodesineIBA 01/2019 - 07/2012
3	Fluorouracil (Carac)FDA LinkGeneric 09/2012 - 07/2003
2	Histone Deacetylase InhibitorsIBA 01/2023 - 07/2015
2	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 11/2009
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 12/2022 - 12/2015
2	liposomal amphotericin B FDA Link 12/2021 - 08/2020
2	Itraconazole (Sporanox)FDA LinkGeneric 12/2021 - 08/2020
2	Fibrin Tissue Adhesive (Fibrin Sealant)IBA 08/2021 - 09/2017
2	Prostaglandins AIBA 08/2021 - 09/2017
2	alectinibIBA 12/2020 - 01/2017
2	Indicators and Reagents (Reagents)IBA 12/2020 - 01/2018
2	Inosine Triphosphate (ITP)IBA 03/2020 - 04/2018
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 11/2018 - 10/2005
2	Immunoconjugates (Immunoconjugate)IBA 06/2014 - 03/2014
2	Immunoglobulins (Immunoglobulin)IBA 03/2014 - 09/2011
2	Antineoplastic Agents (Antineoplastics)IBA 08/2013 - 09/2012
2	plerixafor FDA Link 02/2013 - 02/2011
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 04/2009 - 01/2008
2	hydrogen sulfite (bisulfite)IBA 12/2006 - 09/2003
2	nedaplatinIBA 10/2005 - 07/2003
1	mogamulizumabIBA 12/2023
1	serum P-component (CIt)IBA 11/2023
1	Protein Subunit VaccinesIBA 08/2023
1	Peptides (Polypeptides)IBA 08/2023
1	Glyceraldehyde 3-Phosphate (Glyceraldehyde 3 Phosphate)IBA 01/2023
1	Phenobarbital (Luminal)FDA Link 01/2023
1	Estrogen ReceptorsIBA 01/2023

Therapy/Procedure

31	Therapeutics 01/2024 - 01/2008
18	Drug Therapy (Chemotherapy) 12/2023 - 08/2009
4	Stem Cell Transplantation 05/2022 - 09/2018
4	Adjuvant Chemotherapy 05/2011 - 07/2003
4	Combination Drug Therapy (Combination Chemotherapy) 05/2011 - 07/2003
3	Aftercare (After-Treatment) 11/2018 - 09/2003
3	Immunotherapy 01/2018 - 12/2002
2	Hematopoietic Stem Cell Transplantation 12/2023 - 01/2021
2	Induction Chemotherapy 10/2020 - 01/2013
2	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 03/2020 - 01/2017
2	Art Therapy 08/2019 - 02/2014
2	Highly Active Antiretroviral Therapy (HAART) 08/2019 - 06/2010
2	Remission Induction 06/2018 - 12/2008